Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Head and Neck Neoplasms 16Mouth Neoplasms 7Squamous Cell Carcinoma of Head and Neck 4Oropharyngeal Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Tongue Neoplasms 2Salivary Gland Neoplasms 2Paranasal Sinus Neoplasms 2Nasopharyngeal Neoplasms 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomatitis 1Recurrence 1Precancerous Conditions 1Pharyngeal Neoplasms 1Papilloma 1Neoplasms 1Mucositis 1Leukoplakia, Oral 1Laryngeal papillomatosis 1Adenocarcinoma, Follicular 1

Interventions

Iodine-131 21lenvatinib 17Magnetic Resonance Spectroscopy 17trametinib 13Sorafenib 13Thyrotropin Alfa 12pembrolizumab 11dabrafenib 11Thyroidectomy 10Surgical Procedures, Operative 10Thyroxine 9Paclitaxel 9vandetanib 8selpercatinib 8Sunitinib 7Nivolumab 7Fluorodeoxyglucose F18 7cabozantinib 6anlotinib 6Everolimus 6Biopsy 6pazopanib 5Vemurafenib 5Triiodothyronine 5Specimen Handling 5Saline Solution 5Radiotherapy 5Radiofrequency Ablation 5Iodine-124 5Cyclophosphamide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Celecoxib × Head & Neck × Clear all
NCT00061906 2014-02-11

Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
25 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡